Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Molecular Partners Ag (MOLN) Assets Average (2022 - 2025)

Historic Assets Average for Molecular Partners Ag (MOLN) over the last 5 years, with Q3 2025 value amounting to $145139.3.

  • Molecular Partners Ag's Assets Average rose 6291.3% to $145139.3 in Q3 2025 from the same period last year, while for Sep 2025 it was $145139.3, marking a year-over-year increase of 6291.3%. This contributed to the annual value of $201906.0 for FY2024, which is 1856.04% down from last year.
  • Per Molecular Partners Ag's latest filing, its Assets Average stood at $145139.3 for Q3 2025, which was up 6291.3% from $153509.0 recorded in Q2 2025.
  • Molecular Partners Ag's Assets Average's 5-year high stood at $103.8 million during Q4 2021, with a 5-year trough of $89090.1 in Q3 2024.
  • Moreover, its 5-year median value for Assets Average was $168968.6 (2022), whereas its average is $6.7 million.
  • Per our database at Business Quant, Molecular Partners Ag's Assets Average crashed by 9972.87% in 2022 and then skyrocketed by 6291.3% in 2025.
  • Quarter analysis of 5 years shows Molecular Partners Ag's Assets Average stood at $103.8 million in 2021, then tumbled by 99.73% to $281681.3 in 2022, then decreased by 16.47% to $235277.9 in 2023, then fell by 23.72% to $179477.3 in 2024, then fell by 19.13% to $145139.3 in 2025.
  • Its Assets Average stands at $145139.3 for Q3 2025, versus $153509.0 for Q2 2025 and $168949.2 for Q1 2025.